Title : Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis - |
Author(s) : Sellam J , Riviere E , Courties A , Rouzaire PO , Tolusso B , Vital EM , Emery P , Ferracioli G , Soubrier M , Ly B , Chavez HH , Taoufik Y , Dougados M , Mariette X |
Ref : Arthritis Res Ther , 19 :11 , 2017 |
PubMedID: 28115013 |